Cargando…
Nano-Microparticle Platforms in Developing Next-Generation Vaccines
The first vaccines ever made were based on live-attenuated or inactivated pathogens, either whole cells or fragments. Although these vaccines required the co-administration of antigens with adjuvants to induce a strong humoral response, they could only elicit a poor CD8(+) T-cell response. In contra...
Autores principales: | Cappellano, Giuseppe, Abreu, Hugo, Casale, Chiara, Dianzani, Umberto, Chiocchetti, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228777/ https://www.ncbi.nlm.nih.gov/pubmed/34198865 http://dx.doi.org/10.3390/vaccines9060606 |
Ejemplares similares
-
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
por: Cappellano, Giuseppe, et al.
Publicado: (2019) -
Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process
por: Rolla, Roberta, et al.
Publicado: (2021) -
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
por: Clemente, Nausicaa, et al.
Publicado: (2016) -
Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future
por: Abreu, Hugo, et al.
Publicado: (2021) -
The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
por: Cappellano, Giuseppe, et al.
Publicado: (2020)